Compare Moderna, Inc. (MRNA) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs United Parcel Service Inc — how do they compare? Moderna, Inc. trades at $195.7 (market cap $78.44B), while United Parcel Service Inc trades at $94.5 (market cap $78.52B). The key difference: Moderna, Inc. and United Parcel Service Inc are close in size by market cap, and United Parcel Service Inc pays a 7.11% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and United Parcel Service Inc for 141 Days on average.
| MRNA | UPS | |
|---|---|---|
Market Cap | $78.44B | $78.52B |
Volume | 14,597,511 | 5,159,366 |
Sector | Health | Industrials |
52-Week High | $203.46 | $120.00 |
52-Week Low | $22.36 | $82.87 |
Typical Hold Time | 59 Days | 141 Days |
Enterprise Value | $74.59B | $102.54B |
Dividend Yield | — | 7.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $196.48, up 4.81% amid Nasdaq-100 inclusion news, though it remains well below the analyst consensus target of $115.70. The stock shows bullish technical momentum with recent earnings beats, but faces fundamental challenges with negative profit margins and declining revenue from pandemic-era highs. The company's cash flow improved in 2025, turning positive for the first time since 2022, while its pipeline, including oncology vaccines, attracts investor interest despite valuation concerns.
Outlook: Near-term momentum from index fund buying and pipeline updates may support the stock, but high valuation multiples and persistent losses pose significant risks. Long-term growth depends on successful commercialization of non-COVID products, with current prices reflecting optimistic scenarios. Investors should weigh the potential of the mRNA platform against execution risks and competitive pressures.
UPS trades at $92.28, down 0.89% on the day, with a bearish technical signal despite recent earnings beats. The company maintains solid fundamentals with a P/E of 17.15 and ROE of 29.66%, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. Recent developments include the launch of UPS Secure Commerce and an exclusive TikTok Shop partnership.
The outlook is mixed: analyst consensus price target of $118.67 suggests 29% upside, but technical indicators and recent downgrades highlight near-term pressure. Key risks include fuel costs, domestic volume concerns, and Amazon competition, while the 7% dividend yield provides income support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
